QuickView for cytidine to uridine editing (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
3. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
5. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens

1. Measuring editing activity and identifying cytidine-to-uridine mRNA editing factors in cells and bio…
2. Mouse models as tools to explore cytidine-to-uridine RNA editing.
3. Commitment of apolipoprotein B RNA to the splicing pathway regulates cytidine-to-uridine editing-sit…
4. Identification of the chloroplast adenosine-to-inosine tRNA editing enzyme.
5. RESOPS: a database for analyzing the correspondence of RNA editing sites to protein three-dimensiona…

There were no clinical trials for cytidine to uridine editing